新型冠状病毒 2019 型心肌损伤的发病机制和处理。
Pathogenesis and management of myocardial injury in coronavirus disease 2019.
机构信息
Center for Coronary Heart Disease, Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Center for Cardiovascular Biology and Atherosclerosis Research, Department of Internal Medicine, McGovern School of Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
出版信息
Eur J Heart Fail. 2020 Nov;22(11):1994-2006. doi: 10.1002/ejhf.1967. Epub 2020 Aug 22.
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a major health crisis and a worldwide pandemic. COVID-19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID-19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre-existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID-19 cardiovascular complications.
新型冠状病毒病 2019（COVID-19）的爆发是由严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染引起的，已成为重大的健康危机和全球大流行。COVID-19 的特点是传染性高、潜伏期长、临床表现多样且传播强度大。COVID-19 可导致心肌损伤和其他心血管并发症，尤其是在有基础疾病的老年患者中。本综述总结了 COVID-19 心血管并发症的流行病学特征、潜在机制、临床表现和最新治疗进展。
Zotero 插件